All Stories

  1. Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study

    Article • Journal of Critical Care, June 2015, Elsevier

    Dr Maria-Jose Gimenez, Dr Alejandro Suarez de la Rica

  2. Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections

    Article • Expert Review of Anti-infective Therapy, August 2014, Taylor & Francis

    Emilio Maseda, Dr Maria-Jose Gimenez

  3. Combination of two methods for Legionella disinfection of water systems (cooling towers and potable water) in a Spanish hospital

    Article • International Journal of Infection Control, March 2014, International Federation of Infection Control

    Dr Maria-Jose Gimenez

  4. Bugs, hosts and ICU environment: Countering pan-resistance in nosocomial microbiota and treating bacterial infections in the critical care setting

    Article • Revista Española de Anestesiología y Reanimación, March 2014, Elsevier

    Dr Maria-Jose Gimenez

  5. Repeated Aspergillusisolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection?

    Article • BMC Infectious Diseases, November 2012, Springer Science + Business Media

    Dr Maria-Jose Gimenez, Bernardino Alcazar Navarrete

  6. Clinical features of invasive pulmonary aspergillosis vs. colonization in COPD patients distributed by gold stage

    Article • Journal of Infection, November 2012, Elsevier

    Dr Maria-Jose Gimenez, MD; PhD José L. Hernández

  7. Comparative in vitro activity of common antibiotics and relationship with changes in Streptococcus pneumoniae serotypes causing otitis in children prior to and 10 years after introduction of conjugate vaccines in Spain

    Article • International Journal of Antimicrobial Agents, October 2012, Elsevier

    Dr Maria-Jose Gimenez

  8. Cefditoren and Ceftriaxone Enhance Complement-Mediated Immunity in the Presence of Specific Antibodies against Antibiotic-Resistant Pneumococcal Strains

    Article • PLoS ONE, September 2012, PLOS

    Dr Maria-Jose Gimenez

  9. Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000–May 2001) and 10 years after (May 2010–May 2011) introduction of conjugate vaccines for child immunisation in Spain

    Article • International Journal of Antimicrobial Agents, July 2012, Elsevier

    Dr Maria-Jose Gimenez

  10. Update on the clinical utility and optimal use of cefditoren

    Article • International Journal of General Medicine, May 2012, Taylor & Francis

    Dr Maria-Jose Gimenez

  11. Correlation between clinical parameters characterizing peri-implant and periodontal health: A practice-based research in Spain in a series of patients with implants installed 4-5 years ago

    Article • Medicina Oral Patología Oral y Cirugia Bucal, January 2012, Medicina Oral, S.L.

    Dr Maria-Jose Gimenez

  12. Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009

    Article • BMC Infectious Diseases, September 2011, Springer Science + Business Media

    Dr Maria-Jose Gimenez

  13. Legionella pneumophila isolation rate in a Spanish hospital pre- and post-installation of an electro-chemical activation system for potable water disinfection

    Article • July 2011, World Scientific Pub Co Pte Lt

    Dr Maria-Jose Gimenez

  14. Bacterial clearance from blood in mice infected byS. pneumoniae(penicillin MIC=16 μg/ml) presenting specific IgG (non-protective levels) and treated with sub-therapeutic regimens of cefditoren (a highly bound cephalosporin)

    Article • July 2011, World Scientific Pub Co Pte Lt

    Dr Maria-Jose Gimenez

  15. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus

    Article • International Journal of Antimicrobial Agents, April 2011, Elsevier

    Dr Maria-Jose Gimenez

  16. Predictive model of short-term amputation during hospitalization of patients due to acute diabetic foot infections

    Article • Enfermedades Infecciosas y Microbiología Clínica, December 2010, Elsevier

    Dr Maria-Jose Gimenez

  17. Enhanced In Vivo Activity of Cefditoren in Pre-Immunized Mice against Penicillin-Resistant S. pneumoniae (Serotypes 6B, 19F and 23F) in a Sepsis Model

    Article • PLoS ONE, August 2010, PLOS

    Dr Maria-Jose Gimenez

  18. Ceftaroline (CPT) Comparative In Vitro Activity Against Penicillin (PEN), Cefotaxime (CTX), or Levofloxacin (LVX) Nonsusceptible (NS)S. pneumoniaeIsolates from Invasive (INV) and Lower Respiratory Tract (LRT) Samples.

    Article • April 2009, American Thoracic Society

    Dr Maria-Jose Gimenez

  19. Is There a Relationship Between Monthly Rainfall and the Isolation of Legionella in Potable Water Systems in Spanish Healthcare Facilities?

    Article • Infection Control and Hospital Epidemiology, March 2009, Cambridge University Press

    Dr Maria-Jose Gimenez

  20. β-Lactam Effects on Mixed Cultures of Common Respiratory Isolates as an Approach to Treatment Effects on Nasopharyngeal Bacterial Population Dynamics

    Article • PLoS ONE, December 2008, PLOS

    Dr Maria-Jose Gimenez

  21. Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation

    Article • International Journal of Antimicrobial Agents, August 2008, Elsevier

    Dr Maria-Jose Gimenez

  22. High Protein Binding and Cidal Activity against Penicillin-Resistant S. pneumoniae: A Cefditoren In Vitro Pharmacodynamic Simulation

    Article • PLoS ONE, July 2008, PLOS

    Dr Maria-Jose Gimenez

  23. Decrease in Bacterial Load Versus Resistance Selection of Pneumococcal Subpopulations by β-Lactam Physiological Concentrations over Time: An In Vitro Pharmacodynamic Simulation

    Article • Microbial Drug Resistance, March 2008, Mary Ann Liebert Inc

    Dr Maria-Jose Gimenez

  24. Gaps in antibiotic development: the postmarketing task

    Article • Reviews in Medical Microbiology, January 2008, Wolters Kluwer Health

    Dr Maria-Jose Gimenez

  25. Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones

    Article • International Journal of Antimicrobial Agents, February 2007, Elsevier

    Dr Maria-Jose Gimenez

  26. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: A pooled analysis of seven c...

    Article • Clinical Therapeutics, December 2006, Elsevier

    Dr Maria-Jose Gimenez

  27. Conservative Treatment of Staphylococcal Prosthetic Joint Infections in Elderly Patients

    Article • The American Journal of Medicine, November 2006, Elsevier

    Dr Maria-Jose Gimenez

  28. Urinary Concentrations and Bactericidal Activity Against Amoxicillin-Nonsusceptible Strains of Escherichia coli with Single-Dose, Oral, Sustained-Release Amoxicillin/Clavulanic Acid: A PhaseI, Open-Label, Noncomparative Clinical Trial in Healthy Volunt...

    Article • Clinical Therapeutics, July 2005, Elsevier

    Dr Maria-Jose Gimenez

  29. Does Acetaminophen Interfere in the Antibiotic Treatment of Acute Otitis Media Caused by a Penicillin-Resistant Pneumococcus Strain? A Gerbil Model

    Article • Pediatric Research, December 2003, Springer Science + Business Media

    Dr Maria-Jose Gimenez